Prognostic impact of discordance between triple-receptor measurements in primary and recurrent breast cancer.
Liedtke C, Broglio K, Moulder S, Hsu L, Kau SW, Symmans WF, Albarracin C, Meric-Bernstam F, Woodward W, Theriault RL, Kiesel L, Hortobagyi GN, Pusztai L, Gonzalez-Angulo AM.
Liedtke C, et al.
Ann Oncol. 2009 Dec;20(12):1953-8. doi: 10.1093/annonc/mdp263. Epub 2009 Jul 12.
Ann Oncol. 2009.
PMID: 19596702
Free PMC article.